Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain

dc.contributor.authorRodriguez del Rio, Pablo
dc.contributor.authorCaimmi, Davide
dc.contributor.authorRico, Pilar
dc.contributor.authorVidal, Carmen
dc.contributor.authorCarmen, Moreno
dc.contributor.authorPintoiu, Ileana M.
dc.contributor.authorBeitia Mazuecos, Jose M.
dc.contributor.authorGonzalez de Olano, David
dc.contributor.authorCuesta Alvaro, Pedro
dc.contributor.authorDemoly, Pascal
dc.contributor.authorCalderon, Moises A.
dc.contributor.authoraffiliation[Rodriguez del Rio, Pablo] Hosp Infantil Univ Nino Jesus, Dept Allergy, Madrid, Spain
dc.contributor.authoraffiliation[Rodriguez del Rio, Pablo] Hlth Res Inst Princesa, Madrid, Spain
dc.contributor.authoraffiliation[Caimmi, Davide] Univ Montpellier, Univ Hosp Montpellier, Arnaud de Villeneuve Hosp, Div Allergy,Dept Pulmonol, Montpellier, France
dc.contributor.authoraffiliation[Demoly, Pascal] Univ Montpellier, Univ Hosp Montpellier, Arnaud de Villeneuve Hosp, Div Allergy,Dept Pulmonol, Montpellier, France
dc.contributor.authoraffiliation[Caimmi, Davide] Univ Montpellier, INSERM, IDESP, UMR A11, Montpellier, France
dc.contributor.authoraffiliation[Demoly, Pascal] Univ Montpellier, INSERM, IDESP, UMR A11, Montpellier, France
dc.contributor.authoraffiliation[Rico, Pilar] San Pablo CEU, Fac Med, IMMA, Madrid, Spain
dc.contributor.authoraffiliation[Vidal, Carmen] Complejo Hosp Univ Santiago, Dept Allergy, Santiago De Compostela, Spain
dc.contributor.authoraffiliation[Carmen, Moreno] Hosp Reina Sofia, Red ARADyAL, Inst Maimonides Invest Biomed Cordoba, Cordoba, Spain
dc.contributor.authoraffiliation[Beitia Mazuecos, Jose M.] Hosp Univ Guadalajara, Allergy Dept, Guadalajara, Spain
dc.contributor.authoraffiliation[Gonzalez de Olano, David] Hosp Ramon & Cajal, IRYCIS, Allergy Dept, Madrid, Spain
dc.contributor.authoraffiliation[Cuesta Alvaro, Pedro] Univ Complutense Madrid, Res Support, Comp Serv, Madrid, Spain
dc.contributor.authoraffiliation[Calderon, Moises A.] Imperial Coll London, NHLI, Sect Allergy & Clin Immunol, London, England
dc.contributor.funderALK
dc.contributor.funderStallergenes Greer
dc.date.accessioned2025-01-07T13:27:36Z
dc.date.available2025-01-07T13:27:36Z
dc.date.issued2021-11-15
dc.identifier.doi10.1111/cea.14043
dc.identifier.essn1365-2222
dc.identifier.issn0954-7894
dc.identifier.pmid34747540
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cea.14043
dc.identifier.urihttps://hdl.handle.net/10668/25531
dc.identifier.wosID718352100001
dc.issue.number1
dc.journal.titleClinical and experimental allergy
dc.journal.titleabbreviationClin. exp. allergy
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.page.number167-170
dc.publisherWiley
dc.rights.accessRightsopen access
dc.titleReal-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain
dc.typeletter
dc.type.hasVersionVoR
dc.volume.number52
dc.wostypeLetter

Files